Celanese Corp. (CE) Tops Q2 EPS by 24c; Boosts FY14 EPS Growth Outlook
Get Alerts CE Hot Sheet
Price: $43.31 --0%
Financial Fact:
Continuing operations: 1.84
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Continuing operations: 1.84
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Celanese Corp. (NYSE: CE) reported Q2 EPS of $1.47, $0.24 better than the analyst estimate of $1.23. Revenue for the quarter came in at $1.77 billion versus the consensus estimate of $1.72 billion.
Sees adjusted earnings per share growth in the range of 15 to 17 percent in 2014, up from a prior range of 12 to 14 percent.
For earnings history and earnings-related data on Celanese Corp. (CE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share